Phase I clinical trial - Appareil pulmonaire
J10-MC-JZHB
Appareil pulmonaire
Ouvert depuis le: 06.03.2020
Site: Paris
Public cible
Adulte
A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer
Description de l'essai
The purpose of this study is to determine the recommended phase 2 dose of LY3295668 erbumine in participants with platinum-sensitive, extensive-stage small-cell lung cancer.
Liens utiles
